Brief: Genscript Biotech And Ligand Pharmaceuticals Enter Into Global Omniab Licensing Agreement
02/06/2021 14:03
June 2 (Reuters) - Genscript Biotech Corp 1548.HK :
* GENSCRIPT BIOTECH AND LIGAND PHARMACEUTICALS ENTER INTO
GLOBAL
OMNIAB® LICENSING AGREEMENT
Source text for Eikon: ID:nPn3nnMSza
Further company coverage: 1548.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale